We have previously reported that environmental-level magnetic fields (1.2 mT [12 milligauss], 60 Hz) block the growth inhibition of the hormone melatonin (10 09 M) on MCF-7 human breast cancer cells in vitro. We now report that the same 1.2 mT, 60 Hz magnetic fields significantly block the growth in
Reduction of the earth's magnetic field inhibits growth rates of model cancer cell lines
β Scribed by Carlos F. Martino; Lucas Portelli; Kevin McCabe; Mark Hernandez; Frank Barnes
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 203 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0197-8462
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Small alterations in static magnetic fields have been shown to affect certain chemical reaction rates ex vivo. In this manuscript, we present data demonstrating that similar small changes in static magnetic fields between individual cell culture incubators results in significantly altered cell cycle rates for multiple cancerβderived cell lines. This change as assessed by cell number is not a result of apoptosis, necrosis, or cell cycle alterations. While the underlying mechanism is unclear, the implications for all cell culture experiments are clear; static magnetic field conditions within incubators must be considered and/or controlled just as one does for temperature, humidity, and carbon dioxide concentration. Bioelectromagnetics 31:649β655, 2010. Β© 2010 WileyβLiss, Inc.
π SIMILAR VOLUMES
An effect on the tumor promotion process, as represented by accelerated cell growth, has been indicated as one example of areas that demonstrate the possibility of biological effects of extremely-low frequency magnetic fields. We, therefore, exposed the five cell lines (HL-60, K-562, MCF-7, A-375, a
Ebp1, an ErbB-3 binding protein, translocates from the cytoplasm to the nucleus of human breast cancer cells after treatment with the ErbB-3 ligand, heregulin. The purpose of these studies was to examine the effects of ectopic expression of ebp1 on the biological properties of human ErbB-3-expressin